Page last updated: 2024-11-05

thalidomide and Endocrine System Diseases

thalidomide has been researched along with Endocrine System Diseases in 6 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Endocrine System Diseases: Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.

Research Excerpts

ExcerptRelevanceReference
"Thalidomide is a synthetic glutamic acid derivative first introduced in 1956 in Germany as an over the counter medications."2.50[Current therapeutic indications of thalidomide and lenalidomide]. ( Cosiglio, FJ; Ordi-Ros, J, 2014)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ordi-Ros, J1
Cosiglio, FJ1
KOPF, R1
LORENZ, D1
SALEWSKI, E1
DE JONGE, GA1
Getty, J1
Grunfeld, C1
Homburger, F1
Bajusz, E1

Reviews

1 review available for thalidomide and Endocrine System Diseases

ArticleYear
[Current therapeutic indications of thalidomide and lenalidomide].
    Medicina clinica, 2014, Apr-22, Volume: 142, Issue:8

    Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Antineoplastic Agents; Collagen Diseases; End

2014

Other Studies

5 other studies available for thalidomide and Endocrine System Diseases

ArticleYear
[THE EFFECT OF THALIDOMIDE ON THE FERTILITY OF RATS IN REPRODUCTION EXPERIMENTS OVER 2 GENERATIONS].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1964, May-05, Volume: 247

    Topics: Endocrine System Diseases; Fertility; Pharmacology; Pregnancy; Pregnancy, Animal; Rats; Reproduction

1964
[FETAL DAMAGE CAUSED BY PHARMACEUTICAL AGENTS].
    Folia medica Neerlandica, 1965, Volume: 8

    Topics: Abnormalities, Drug-Induced; Endocrine System Diseases; Fetal Diseases; Humans; Morphine Dependence;

1965
Turning the corner on wasting? A symposium on wasting disorders.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cachexia; Endocrine System Diseases; Humans; M

1995
State of the art in wasting: an interview with Carl Grunfeld, PhD. Interview by Jeff Getty.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Animals; Cachexia; Endocr

1995
New models of human disease in Syrian hamsters.
    JAMA, 1970, Apr-27, Volume: 212, Issue:4

    Topics: Adenoma; Adrenal Gland Neoplasms; Animals; Cardiomyopathies; Cricetinae; Cyclamates; Disease Models,

1970